May. 26 at 6:25 PM
$APT International rescue committee is stating this Ebola outbreak is at risk of becoming the worst in history.
Meanwhile, we sit here, conservatively below the forward book value of
$6.60 even if this outbreak contributes
$0 to sales and the company does no buybacks. I would bet there will be marginally increased sales even if we somehow manage to not import cases.
I think the share price still reflects an attractive conservative valuation based on zero likelihood of this spreading beyond Africa.
Shares have also moved into the coveted LT golden weekly cross, meaning share price is likely to remain higher for longer and P/E expansion can easily run back into the high 20s, with price/book finally returning to more healthy historical levels above 1.15x
My price target remains
$7.37 under the assumption this outbreak remains contained to Africa.
https://abcnews.com/amp/International/ebola-outbreak-risks-becoming-deadliest-record-irc-warns/story
